Similar articles for PMID: 31580868

Year	Number of Results
1992	1
1996	1
1999	1
2001	1
2003	1
2005	1
2008	1
2010	1
2011	1
2012	2
2013	2
2014	2
2015	13
2016	17
2017	19
2018	19
2019	16
2020	9
2022	1
2024	0

1

Carbapenem/β-lactamase inhibitor combination in complicated urinary tract infection.

Tang HJ, Lai CC, Chao CM. Tang HJ, et al. J Infect. 2020 Jan;80(1):121-142. doi: 10.1016/j.jinf.2019.09.011. Epub 2019 Sep 30. J Infect. 2020. PMID: 31580868 No abstract available.

2

Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae.

Lee YR, Baker NT. Lee YR, et al. Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1411-1419. doi: 10.1007/s10096-018-3260-4. Epub 2018 Apr 19. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29675787 Review.

3

Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.

Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB. Carmeli Y, et al. Lancet Infect Dis. 2016 Jun;16(6):661-673. doi: 10.1016/S1473-3099(16)30004-4. Epub 2016 Apr 20. Lancet Infect Dis. 2016. PMID: 27107460 Free article. Clinical Trial.

4

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.

Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE; Antibacterial Resistance Leadership Group. Tamma PD, et al. Clin Infect Dis. 2015 May 1;60(9):1319-25. doi: 10.1093/cid/civ003. Epub 2015 Jan 13. Clin Infect Dis. 2015. PMID: 25586681 Free PMC article.

5

[Current chemotherapy in urogenital infections. Part 5:Macrolide antibiotics, carbapenems, monobactams, beta-lactamase inhibitors].

Hofstetter A. Hofstetter A. Fortschr Med. 1992 Jan 20;110(1-2):45-6. Fortschr Med. 1992. PMID: 1563698 German. No abstract available.

6

Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.

Abe Y, Inan-Erdogan I, Fukuchi K, Wakabayashi H, Ogawa Y, Hibino S, Sakurai S, Matsuhashi K, Watanabe Y, Hashimoto K, Ugajin K, Itabashi K. Abe Y, et al. J Infect Chemother. 2017 Aug;23(8):517-522. doi: 10.1016/j.jiac.2017.04.006. Epub 2017 May 18. J Infect Chemother. 2017. PMID: 28528936

7

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.

Ng TM, Khong WX, Harris PN, De PP, Chow A, Tambyah PA, Lye DC. Ng TM, et al. PLoS One. 2016 Apr 22;11(4):e0153696. doi: 10.1371/journal.pone.0153696. eCollection 2016. PLoS One. 2016. PMID: 27104951 Free PMC article.

8

Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.

Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R. Senard O, et al. Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):121-129. doi: 10.1007/s10096-019-03701-0. Epub 2019 Sep 11. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31512147

9

Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.

Kim SA, Altshuler J, Paris D, Fedorenko M. Kim SA, et al. Int J Antimicrob Agents. 2018 Jan;51(1):155-158. doi: 10.1016/j.ijantimicag.2017.09.013. Epub 2017 Sep 21. Int J Antimicrob Agents. 2018. PMID: 28943367

10

Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection.

Senol S, Tasbakan M, Pullukcu H, Sipahi OR, Sipahi H, Yamazhan T, Arda B, Ulusoy S. Senol S, et al. J Chemother. 2010 Oct;22(5):355-7. doi: 10.1179/joc.2010.22.5.355. J Chemother. 2010. PMID: 21123160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year